A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.
Researchers found that an AI tool called Unfold AI, developed by researchers at UCLA and Avenda Health, accurately estimates prostate tumor volume and helps identify patients with a higher chance of successful treatment.